CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-04 | Postma Robert W Director | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2021-03-04 | Huang James Director | Grant or award | +8,333 | 8,333 | ||
| 2021-03-04 | Huang James Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2021-03-04 | BUCHI J KEVIN Director | Grant or award | +4,167 | 4,167 | ||
| 2021-03-04 | BUCHI J KEVIN Director | Grant or award · Stock Option (right to buy) | +31,250 | 31,250 | ||
| 2021-03-04 | Bowden Christopher Director | Grant or award | +4,167 | 4,167 | ||
| 2021-03-04 | Bowden Christopher Director | Grant or award · Stock Option (right to buy) | +31,250 | 31,250 | ||
| 2021-03-04 | Buck Jill EVP, GM Gene Therapy | Grant or award | +31,500 | 231,016 | ||
| 2021-03-04 | Buck Jill EVP, GM Gene Therapy | Grant or award · Employee Stock Option (right to buy) | +236,250 | 236,250 | ||
| 2021-03-04 | Hadfield Robert Chief Legal Officer and Sec. | Grant or award | +43,500 | 176,819 | ||
| 2021-03-04 | Hadfield Robert Chief Legal Officer and Sec. | Grant or award · Employee Stock Option (right to buy) | +326,250 | 326,250 | ||
| 2021-03-04 | Hagen Heidi Interim CEO | Grant or award | +90,000 | 122,119 | ||
| 2021-03-04 | Hagen Heidi Interim CEO | Grant or award · Employee Stock Option (right to buy) | +675,000 | 675,000 | ||
| 2021-03-04 | De Groot Eleanor EVP, GM Cell Therapy | Grant or award | +50,825 | 257,238 | ||
| 2021-03-04 | De Groot Eleanor EVP, GM Cell Therapy | Grant or award · Employee Stock Option (right to buy) | +381,188 | 381,188 | ||
| 2021-01-08 | Buck Jill EVP, GM Gene Therapy | Sale | −27,894 | $3.12 | $87K | 199,516 |
| 2021-01-08 | Lafond Kevin G SVP, Treasurer & CAO | Sale | −18,020 | $3.09 | $56K | 63,965 |
| 2021-01-08 | Hadfield Robert General Counsel and Secretary | Sale | −26,500 | $3.12 | $83K | 133,319 |
| 2021-01-04 | De Groot Eleanor EVP, GM Cell Therapy | Sale | −21,620 | $2.72 | $59K | 206,413 |
| 2021-01-04 | Cooper Laurence James Neil President and CEO | Sale | −105,693 | $2.71 | $286K | 1,799,280 |
Page 7 of 16 · 304 trades